Sleep Apnea Devices Market — Global Industry Insights, Outlook Size, Share and Opportunity Analysis, 2017–2025

Sleep apnea is a chronic respiratory sleep disorder that is commonly characterized by disruption of breathing while sleeping. This is characterized by conditions such as shallow periods of breathing or occurrence of breaks and pauses during sleep. The duration pauses can be for a few seconds or can last for several minutes. These disruptive events can occur multiple times during the night. People with loud snoring habits are most vulnerable to sleep apnea. Resumption of breathing after these pauses are mostly followed by choking or snorting sounds. Most people remain undiagnosed of sleep apnea, as it occurs during the night and is difficult to be detected during routine hospital visits. Apnea essentially is the squeezing of air that passes the blockage, while breathing and results in loud snoring. These blockages are mostly encountered in overweight and obese people. People suffering from diabetes are more likely to be victims of sleep apnea. Three major types of sleep apnea are obstructive sleep apnea (OSA), central sleep apnea (CSA) and mixed sleep apnea, which is a combination of the two. Obstructive sleep apnea is the most commonly found form of sleep apnea in which the breathing is interrupted by blockage of airflow.

Fill the form for an exclusive sample of this report @ https://www.coherentmarketinsights.com/insight/request-sample/414

Apart from obesity, various factors such as smoking, hereditary existence, menopause, consumption of medicines with sedative effects, having long neck, alcohol consumption, and improper sleeping habits are also responsible for prevalence of this disorder. Sleep apnea is mainly encountered among the geriatric population with growing levels of obesity. Oventus Inc. suggests that OSA prevails in approximately 3% to 7% of adult men and in 2% to 5% of adult females. In addition to this, 50% of the general population are snorers indicating the fact that this population is potential buyers of the sleep apnea devices. Around 100 million people across the globe are suspected to suffer from OSA in 2014, though the majority of this population remains undiagnosed. Sleep apnea can be treated through multiple treatment options such as natural recovery by changing everyday habits and lifestyle, as well as use of sleep apnea devices such as continuous positive airway pressure (CPAP) devices or wearable forms such as mandibular advancement devices (MAD), position pillows, dental devices or tongue retaining devices. Sleep apnea can also be treated through surgical method in severe cases.

Positive Airway Pressure (PAP) devices segment to account for highest share of the global sleep apnea devices market:

The global sleep apnea devices market can be segmented on the basis of product type and end users

On the basis of product type, the global market can be segmented as:

  • Therapeutic devices – These are further sub- segmented as:

  • PAP devices

  • Facial interfaces

  • Oxygen concentrators

  • Adaptive servo- ventilation instruments

  • Airway clearance systems

  • Others

  • Diagnostic devices- These are further sub- segmented as:

  • Polysomnography (PSG) devices

  • Respiratory polygraphs

  • Single channel screening devices

  • Actigraphy systems

    On the basis of end user, the global market can be segmented as:

  • Hospitals

  • Home Care Settings

  • Sleep Laboratories

  • Others

The North American share to contribute the highest of the sleep apnea devices market

North America dominates the global sleep apnea devices market, followed by Europe and Asia Pacific respectively. High awareness among the populace and favorable reimbursement scenario make North America a key market for sleep apnea devices. Several other factors such as venture capital funding, new legislation of PAP devices and growth of funding and grants for development in manufacturing units of sleep apnea devices are prime reasons to boost market growth in several European countries.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/414

Well established presence of multiple sleep apnea treating devices results in dominance of ResMed Inc (US) on global sleep apnea devices market

The global sleep apnea devices market is prominently driven by key players such as ResMed Inc., Phillips Healthcare, Fisher and Paykel Healthcare Ltd. These companies have their products selling over several countries, prominently in US and Europe, and has established a dominance in the field of sleep apnea devices industry due to their high investments in R&D and distribution force of strong sales. Following are the other players in global sleep apnea devices market which include SomnoMed Ltd., Weinmann Medical Devices GmbH, Compumedics Ltd., Whole You Inc., BMC Medical Co. Ltd, and Braebon Medical Corporation.

ABOUT US:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Advertisements

Bone Growth Stimulator Market — Global Industry Insights and Opportunity Analysis, 2016–2024,

Bone Growth Stimulator Market Overview:

Bone growth stimulators or BGSs are supplemental devices that are worn after a lumbar (low back) or cervical (neck) spine surgery. Bone growth stimulators can be used to assist spinal bone fuse after a failed fusion procedure. Bone growth stimulation for the cervical and lumbar spine has significant benefits after a fusion procedure. Various doctors recommend BGS for post-operative lumbar and cervical cases. A bone growth stimulator sends low intensity electrical signals to the site of fusion. These electrical signals trigger natural bone healing process of the body, which are sometimes impaired in surgery patients. The global demographic scenario is quite diverse. For instance, India is a country with more than half of the population in the youth bracket, whereas China and the U.S. have the maximum geriatric population. Bone growth stimulators have observed an implausible demand in the past few years. The early development of BGS began in the U.S. and the innovation in technology has made developed and sophisticated products to enter the market.

According to the International Osteoporosis Foundation, osteoporosis causes around 8.9 million fractures per year that is around one osteoporotic fracture every 3 seconds. Moreover, osteoporosis is expected to affect around 200 million women worldwide. Around 80%, 75%, 70% and 58% of forearm, humerus, hip and spine fractures, respectively, affects women. A fracture, especially in the spinal cord requires bone surgery. Out of these surgeries, a significant number of patients will need bone growth stimulators due to steady recovery. This in turn will drive the growth of the overall bone growth stimulator market during the forecast period.

Fill the form for an exclusive sample of this report @ https://www.coherentmarketinsights.com/insight/request-sample/225

Bone growth stimulator market Taxonomy

On the basis of type of product, the global bone growth stimulator market is classified into:

Pulsed Electromagnetic Field (PEMF) Devices

Capacitive Coupling (CC) Devices

Combined Magnetic Field (CMF) Devices

Ultrasound Bone Growth Stimulators Surgical Devices

Invasive Electrical Bone Growth Stimulators

On the basis of type of application, the global market is classified into:

Trauma injury and Fractures

Spinal Fusion

Osteogenesis

Some of the factors such as rise in per capita healthcare spending, increase in personal income, and improvement in healthcare sector will boost growth of the market in bone growth stimulator, globally. Nonetheless, a variety of factors such as uncertainty about efficacy, and availability of alternative therapies may hinder the growth of the overall market.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/225

Increasing prevalence of vertebral fractures, especially in the geriatric population will drive the overall bone growth stimulator market

According to the International Osteoporosis Foundation, the number of vertebral fractures that are not recognized is as high 45% in North America, and 46% in Latin America. After a surgery for a vertebral fracture, there is a high risk of requiring hospitalization for another fracture in the following years. To decrease the morbidity rates in patients with a history of bone surgeries, bone growth stimulators are used extensively. As the number of cases is increasing at an alarming rate, so is the need for bone growth stimulators. This will encourage the growth of the global bone growth stimulator market in the forecast period.

As per the International Osteoporosis Foundation, white women aged 50 years are at 16% lifetime risk of occurrence of a vertebral fracture, whereas the percentage is 5 for white men. The staggering percentage of the population with risk of vertebral fracture above the age of 50 will be responsible for increased number of bone surgeries, thereby augmenting the growth of bone growth stimulators. By geography, North America is likely to dominate the bone growth stimulator industry owing to various factors such as consumer awareness about treatments related bone fracture and injury and high healthcare expenditure. Western Europe will follow North America in terms of market share. Availability of advanced public health systems and subsidies, along with high adoption of new technologies such bone growth stimulators in this region are some of the factors for this region’s high market share.

Some of the companies operating in the bone growth stimulator market in the current scenario are Orthofix International N.V., Aetna Inc., DJO LLC, Smith & Nephew, Zimmer Biomet Holdings Inc., Ossatec Benelux BV, Elizur, Bioventus LLC., Orchid Medical, IGEA S.p.A, and Verve Consulting Inc.

ABOUT US:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Gastroscopy Devices Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

Gastroscopy Devices Market Overview:

Gastroscopy is a type of endoscopy performed for diagnosis of diseases pertaining to esophagus, stomach, and upper part of small intestine. It is also called upper gastrointestinal endoscopy. It is one of the most important discoveries in the field of medical science. Esophagoscope was also a type of endoscopy that was used for diagnosis and treatment procedures of esophagus. Gastroscopy has replaced esophagoscopes completely. The only difference between esophagoscope and gastroscope is the length of gastroscope that is longer than esophagoscopes. Gastroscopy can also be performed to detect cancers. This procedure is recommended to diagnose problems related to the esophagus or stomach. The device has a light and a camera at the end of the probe that is used to see the esophagus, upper intestine and stomach clearly. It is also used to investigate problems related to swallowing, ulcers, and blockage in esophagus. This procedure allows practitioners to study the mucous membrane of the stomach. Gastroscopy are broadly classified into two types namely diagnostic gastroscopy used to diagnose or confirm diagnosis and treatment gastroscopy for therapeutic purposes. Esophagus cancer is the eighth-most common cancer in the world. As per the report of World Cancer Research Fund International, there were around 456,000 new esophagus cancer cases diagnosed in 2012. Gastroscopy is considered as the most preferred option for screening of esophagus cancer and polyps by most gastroenterologists and thus, the gastrointestinal endoscopy devices market is projected to witness significant traction in the foreseeable future.

High Incidence of Esophageal Cancer Fueling Gastroscopy Devices Market Growth

Esophageal cancer is of two types namely, adenocarcinoma and squamous cell carcinoma. Esophageal cancer can occur due to various reasons such as gene type that includes gene mutations or damage involved in cell divisions. As per results of an independent study, overweight and obesity increases the risk of esophageal cancer by 48% per 5 BMI units. Polyp detection rate of esophagus and stomach depend upon the proportion of mucosal surface diagnosed and correlates to time dedicated for diagnosis. Gastroscopes consist of a flexible tube with a high definition camera at the end of the probe. The quality of camera defines the quality of diagnosis. The long length of device is used to examine the complete length of the esophagus.

Fill the form for an exclusive sample of Gastroscopy Devices Market report @ https://www.coherentmarketinsights.com/insight/request-sample/132

Gastroscopy Devices Market: Drivers and Restraints

The global gastrointestinal endoscopy devices market is expected to be fueled by advancements in endoscopy technology. Key drivers of the market are increasing cases of esophageal cancer and polyps, growing ageing population, family history of cancer, and changing lifestyle. Increasing government initiatives to diagnose and treat early stage cancers are also expected to fuel gastrointestinal endoscopy devices market. For instance, in 2014, The European Society of Gastrointestinal Endoscopy (ESGE) and United European Gastroenterology (UEG) created a community of endoscopy services across Europe, collaborating with each other to provide high quality, safe, accurate, patient-centred and accessible endoscopic care. The lack of awareness, dearth of experienced professionals, lack of reimbursement policies, and increasing cases associated with bio-dirt is expected to hinder growth of the market.

Gastroscopy Devices Market Taxonomy

The gastroscopy devices market is classified on the basis of product type and end user.

On the basis of product type, the global gastroscopy devices market is segmented into the following:

  • Flexible Video Gastroscope

  • Flexible Non-video Gastroscope

On the basis of end user, the global gastroscopy devices market is segmented into the following:

  • Hospitals

  • Ambulatory Surgical Centers

  • Clinics

Gastroscopy Devices Market: Overview

Technological advancements in gastroscopy technique are expected to drive growth of the market for gastroscopy device, as these significantly improve detection rate as compared to other conventional procedures. Practitioners prefer using flexible gastroscope over non-flexible gastroscopes due to high quality, less breakage problems and high illumination for better imaging provided by the former. Increasing awareness among practitioners of using the advanced gastroscopy over white light traditional gastroscopy is showing a significant growth towards flexible video gastroscopy. Increasing cases of biodirt provides opportunity to gastroscopy manufacturers to introduce products with innovative features to avoid such cases of infections. Hospital end user segment is expected to remain dominant in the market over the foreseeable future.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/132

Key players operating the gastroscopy devices market include Olympus, Karl Storz, Sono Scape, Endomed, Medigus, Fujifilm Holdings Corporation and Huger.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Dental Equipment Market Value To Surpass Us$ 10.0 Billion By 2024

The Global Dental Equipment Market was valued at US$ 6,342.3 million in 2015 and is projected to expand at a CAGR of 4.7% during 2016–2024, according to a new report published by Coherent Market Insights.Increasing prevalence of poor oral health is increasing patient visits to dental clinics and in turn, is increasing demand for dental equipment.

Changing eating habits has led to increase in dental caries and infection among children and adults alike. High treatment costs and lack of insurance coverage dissuades a majority of the population from visiting a dentist even in developed economies such as the U.S. and U.K. However, the Medicaid is working towards increasing dental insurance coverage across the U.S. through its regional expansion plans. Besides, advent of advanced technological dental equipment such as CAD/CAM, cone beam CT systems and 3D printed dental equipment helps improve therapy outcomes and provide minimal treatment pain, which in turn enhances the patient’s experience.

Fill the form for an exclusive sample of this report @ https://www.coherentmarketinsights.com/insight/request-sample/85

Launch and adoption of new treatment technologies and equipment is a vital factor fueling growth of the global dental industry. 3D printing is one such technology which is playing a role of a key game changer in various dental applications. Due to this, companies manufacturing dental equipment are expanding their product portfolio related to 3D products in order to sustain their market share. For instance, Planmeca Oy launched Creo 3D printer for dental professionals in March 2016. This Digital Light Processing (DLP) 3D printer allows the dentist to custom-print dental implants, splints, surgical guides, temporary fillings, and other medical models. Planmeca Oy also launched a number of new dental consoles—Evolution 12 O’Clock (pictured), Evolution Central Island Console, and Evolution Side Console in November 2016. These consoles have an added advantage of supporting forward integrated with future technologies.

The dental equipment market is witnessing a trend of consolidation. Dentsply International and Sirona Dental Systems merged in February 2016 to form Dentsply Sirona, Inc.—the largest manufacturer of dental equipment and technologies. Post-merger, the company acquired MIS Implants Technologies Ltd.—an Israel-based dental implant systems manufacturer—in June 2016 for US$ 375 million. This acquisition would help Dentsply Sirona, Inc. increase growing demand for dental implants, especially in the MEA region. Other leading market players such as Planmeca Oy are also expanding inorganically. Planmeca Oy expanded its product portfolio through the inclusion of CAD/CAM Restorative System developed by E4D Technologies, LLC, following the acquisition of the latter in December 2013. Through this acquisition, the Planmeca Oy obtained a competitive edge in providing integrated digital dental solutions to dentists and dental laboratories. Consistent introduction of new devices and equipment would enable existing and new dental clinics and laboratories offer improved treatment solutions to their patients.

Increasing insurance coverage is further analyzed to boost market growth for dental equipment and imaging devices. According to the American Dental Association, 29 states in the U.S. extended dental Medicaid benefits to population in their respective states (as of March 2015). Demand for Medicaid dental services is increasing with expanding coverage of Medicaid dental services across different states in the U.S. According to the statistics of National Health Smile organization, approximately 88% of the U.K. adult population in 2016 did not have dental insurance.

Get a discount on this report : https://www.coherentmarketinsights.com/insight/request-discount/85

Key takeaways of the dental equipment market:

  • The global dental equipment market is expected to expand at a CAGR of 4.7% during the forecast period due to increasing dental insurance and dental tourism in emerging economies in Asia and Latin America
  • In terms of equipment, dental system and parts segment holds the largest market share and is expected to reach a value of US$ 2,363.3 million in 2017. Increasing demand for dental equipment accessories and parts is fueling growth of the segment.
  • Adoption of dental equipment in dental clinics is expected to increase rapidly, with growing number of dental clinics across the globe
  • Although, North America led the global dental equipment market in 2015 (in terms of revenue), Asia Pacific is projected to be the fastest growing dental equipment market expanding at a CAGR of 5.6% during the forecast period. Factors contributing to rapid growth rate include increasing medical tourism for dental care and growing distribution network of dental equipment manufacturers in this region.
  • The global dental equipment market is experiencing consolidation, with leading players such as Dentsply Sirona, Inc. and Planmeca Oy cannibalizing each other’s shares in this industry

About Coherent Market Insights:

Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702

Email:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Pharmacy Automation Market – Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis, 2017–2025

Pharmacy automation is a mechanical process where handling and distribution of medications takes place in hospital pharmacy or at retail pharmacy. It includes any pharmacy task that involves counting of small objects such as tablets or capsules, measuring and mixing of powders and liquids for compounding, tracking and updating customer information in databases such as personally identifiable information (PPI), drug interaction risk detection, medical history and inventory management. The pharmacy automation market is expected to favor the growth owing to features such as system integration, which increases the productivity and time to clinicians for patient care.

Fill the form for an exclusive sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/472

Furthermore, demand for pharmaceutical products, technologically advanced robotic equipment and tools to perform operations at faster rate pharmacy automation is required in the near future. Whereas, constant developments in technology favors dispensing of prescription medications safer, more accurate and more efficient. Pharmacy automation has helped to provide improved workflow and efficiency to pharmacist as pharmacy automation can manage over 200-300 medications and patient information in an effective and secure manner. Furthermore, increasing government initiatives to improve healthcare infrastructure in emerging economies such as India and China is in turn expected to fuel growth of the pharmacy automation market.

  • Pharmacy Automation Market Taxonomy

  • By Product Type

  • Automated Medication Dispensing

  • Automated Storage and Retrieval Systems

  • Automated Packaging and Labeling

  • Tabletop Tablet Counter

  • Automated Compounding Devices

  • By End-User

  • Retail Pharmacy

  • Hospital Pharmacy

Increase in need to reduce medication errors fuels the pharmacy automation market

Medication errors such as failure in the drug prescription or dispensing process is lethal to patients, which occurs due to increase in number of customers and work load on pharmacist that encourages the pharmacist to buy pharmacy automation. Whereas pharmacy automation systems in hospital or at retail pharmacy manages, track drug, supplies health information related to patient so that replenishing of only required items is performed. Additionally, pharmacy automation market is expected to gain traction due to its transparent tracking systems as pharmacy automation accurately maintain the record of medications expiry date and physical quantities which helps to reduce the medication error. According to National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) around 0.1 million people die annually due to medical errors in hospital in 2014.

Request for table of content : https://www.coherentmarketinsights.com/ongoing-insight/toc/472

Regional growth engines for pharmacy automation market

Increase in number of drug prescriptions at pharmacies due to growth in aging population in North America and increase in insurance coverage in the U.S. has elevated the burden from healthcare system of the country, which has highlighted that there is need of improvement in management of work, which is possible by using pharmacy automation.

Furthermore, rapid rise in number of patients and demand for quality care is expected to have a positive impact and also increase in technology advancement in healthcare IT infrastructure also boost the pharmacy automation market in Latin America, Middle East, Africa and Asia Pacific.

Key players to support pharmacy automation market

Technological advancement in pharmacy automation systems have improved pharmacy operation which leads to competition in various manufactures to innovate the product. For example Becton Dickinson and Company developed Cato Mediation Workflow software with an optional camera-based visual documentation hardware that provides visual documentation of syringe, vial and IV container information. Key player operating in pharmacy automation market include Baxter International Inc., Cerner Corporation, Becton Dickinson and Company, McKesson Corporation, Swisslog Holdings AG, Capsa Healthcare, ScriptPro LLC, Yuyama Co., Ltd., Omnicell Inc. and Talyst, Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Medical Specialty Bags Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

Medical specialty bags are specially designed bag for use in various medical areas such as in the collection and storage of blood samples, urine collection, enteral feeding and sterile packaging. This bags are most probably used in hospitals for the maintenance of sterilized condition of blood sample which helps in control of disease spreading and in leakage of medicines or blood samples. Blood bags are sterile bags and are nontoxic or reduce the toxicity and can store the blood for a relatively long period. Therefore, they are used in blood collection and storage of blood, especially in blood banks.

Fill the form for an exclusive sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/509

The anesthesia breathing bags are the breathing bags used with face mask that can be placed over the mouth and nose of the patients and provides oxygen for complete breathing. This bags are squeezed and pushes the oxygen flow in the patient’s lungs. This helps in reducing fatigue of hands and also provides firm grip to the hands and are comfortable in use for the patients. This bags are available in various size and are made up of thin durable designs. The ostomy collection bags are used in collection waste from surgically diverted biological system such as colon, ileum, and bladder as ostomy bags are airtight and watertight.

Medical specialty bags market taxonomy

Medical Specialty Bags Market by Product Type:

  • Anesthesia breathing bags
  • Bile collection bags
  • Blood bags
  • Continuous ambulatory peritoneal dialysis (CAPD) bags
  • Enema bags
  • Enteral feeding bags
  • Intravenous fluid/infusion bags
  • Ostomy collection bags
  • Resuscitation bags
  • Urinary collection bags
  • Others

Medical Specialty Bags Market by Geography:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

Rise in the prevalence of high blood pressure and increase in chronic kidney disease globally expected to boost the growth of medical specialty bags market

The rise in global aging population, rise in chronic disease cases, increase in health care expenditure and disposable income are the major factors leading to the growth of the medical specialty bags market. Moreover, rise in blood infusion emergencies and increased use of blood bags further augments market growth.

Geographically North America holds the largest market in the medical specialty bags market. Due to the high prevalence of diseases, increase in obesity population, acceptance in new and innovative products and better infrastructure investments support of health care facilities are the major factors driving the growth of medical specialty bags market in North America.

Centers for Disease Control and Prevention (CDC), in 2017 around 30 million (15%) U.S. adults are estimated to have chronic kidney disease and around 48% of those with severely reduce kidney function, and 96% people are suffering with kidney damage. As there is a strong economic growth in this country, rapid growth of medical infrastructure, rise in disposable income and increase in awareness and demand for healthy life, which has led to increase the demand for medical specialty bags.

Rise in incidence of blood infusion emergencies and introduction of PVC free bags is the major factor that drive the blood bag market. This bags are general used for the blood samples collections or for the storage during the heart surgery period. According to the World Health Organization (WHO), worldwide it was estimated that around 7.5million deaths occurred due to high blood pressure. As per Heart Foundation it was estimated that around 4.6 million (32%) Australians aged 18 years and over had high blood pressure in 2012, and out of this around 23.6% women were more likely to have uncontrolled high blood pressure.

Request for table of content : https://www.coherentmarketinsights.com/ongoing-insight/toc/509

Major Market Players of Medical Specialty Bags Include:

  • Braun Melsungen AG,
  • Baxter International, Inc.
  • Coloplast A/S
  • ConvaTec, Inc.
  • Hollister Incorporated
  • Medline Industries Inc.
  • Nolato AB
  • R. Bard, Inc.
  • Macopharma SA
  • Terumo Corporation
  • Smiths Medical
  • Fresenius SE & Co. KGaA

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Nebulizers Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

Nebulizers are drug delivery devices that are used to administer medicines in the form of a mist inhaled into the lungs. This drug delivery method helps in the administration of drugs such as corticosteroids, bronchodilators and anti-inflammatory medications. Nebulizers are mainly used for patients suffering from asthma, cystic fibrosis, chronic obstructive pulmonary disease (COPD) and other respiratory diseases or disorders. It is much comfortable to use than other forms of ingested medicines, as it targets the respiratory area directly, thus reducing side effects and harm to other body organs and cells. Nebulizers are especially used for delivery of drug to breathing passages, reduce bulging of mucous membrane, to reduce irritation caused by pollutants and activate and thin out discharge. These devices are specially developed for adults and children who are not able to handle inhalers.

Get a trending sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/545

The use of nebulizer depends on the illness for which it is designed to treat. Various considerations to be taken care of while using a nebulizer are as follows:

  • The appropriate method of using the nebulizer

  • Ways to keep the nebulizer clean for maximum safety and effectiveness

Nebulizers Market taxonomy:

On the basis of product type, the nebulizers market is classified into:

  • Ultrasonic

  • Pneumatic

  • Mesh

Ultrasonic nebulizers include portable and standalone nebulizers.

Pneumatic nebulizers are further classified into:

  • Breath Actuated nebulizers

  • Vented nebulizers

Also, mesh nebulizers are also further classified into:

  • Static type nebulizers

  • Vibrating type nebulizers

Pneumatic nebulizers hold the major share in nebulizers market due to their ease of handling, efficient design and low cost.

On the basis of end user, the nebulizers market is classified into:

  • Hospitals

  • Clinics

  • Ambulatory Surgical Centers

  • Home Care Settings

Product innovation driving the preference for nebulizers in treating respiratory conditions

The advanced nebulizers that features aerosol drug delivery technology with minimal drug wastage is expected to drive the nebulizers market growth. Patients play a vigorous role in supervising their diseases by choosing for devices that assist them in diagnosis and treatment at the comfort of their own homes. This shift in patient preferences will strengthen the global nebulizer market growth scenario in the near future. Also the rise in respiratory cases form a major factor. According to World Health Organization (WHO), around 15.7 million people were reported with Chronic Obstructive Pulmonary Disease (COPD) in the U.S. in 2016 which showed a significant increase of 6.4% from 2015.

Nebulizers are also for a variety of diagnostic procedures among which the principal one is in diagnosis of lung function and bronchial activities. This has also added to the rise in demand for nebulizers in the market by the professionals for clinical use and monitoring of various associated respiratory disorders.

Request for table of content : https://www.coherentmarketinsights.com/ongoing-insight/toc/545

Medical reimbursement supporting the North America nebulizer market growth

There are guidelines laid for nebulizers which facilitates its proper usage. The Centers for Medicare & Medicaid Services, and United HealthCare Services, Inc. have defined guidelines for the proper usage of nebulizers in different respiratory issues. In addition to that there are various reimbursement policies that fuel the growth of the market, for instance, policies by Medicaid & Healthcare Partnership in 2012 helped in the easy purchase of nebulizers. Under Hawaii Medical Service Association, in 2014, several cover plans were made for the easy purchases of small volume and large volume nebulizers.

Also, there exists a rental market for nebulizers that assists the usage of these devices in home care settings.

Since nebulization is a spraying technique, therefore the dispersion and wastage of the drug during delivery to the respiratory tract is one of the major restraint for the growth of nebulizers market. Moreover, low consumer switching cost and availability of alternative therapies increases the threat of substitute products.

By geography, North America holds the major share in the global nebulizers market because of the availability of reimbursement and increasing incidence of respiratory diseases.

Key players in the global nebulizers market are GE Healthcare Ltd, Agilent Technologies, GF Health Products, Philips Healthcare CareFusion Corporation, PARI Respiratory Equipment, Covidien plc and Omron Healthcare Co. The players are undertaking various clinical trials and development activities in an endeavor to improve therapeutic effect of the drug. Theravance Biopharma and Mylan announced the initiation of phase 3 studies of revefenacin at the American Thoracic Society (ATS) International Conference in 2017. Revefenacin is a once-daily long acting muscarinic antagonist (LAMA) nebulized therapy. Development of such drugs intended to be delivered via nebulization will also support propelling the growth for nebulizers market. Also Vectura received FDA approval to start testing a smart technology of nebulizers to improve asthma therapies in children.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com